Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.
|
|
|
- Kevin Gilmore
- 6 years ago
- Views:
Transcription
1 Blood Screening Assays CTS lab locations where assays are performed are indicated by alpha codes D, P, and T. D= performed in Dallas lab FEI: P= performed in Phoenix lab FEI: T= performed in Tampa lab FEI: ABO/Rh (P, D, T) Manufacturer: Diagast, Loos Cedex, France for Beckman Coulter Test Name: Beckman Coulter PK System Blood Grouping and Phenotyping ReagentsPK7200 and PK7300 Automated Immunohematology Analyzers License: U.S. License No Alternate ABO/Rh (P, D, T) Manufacturer: ImmucorGamma, Norcross, GA Test Name: Reagent Red Blood Cells for ABO Serum Grouping, Blood Grouping Reagents Anti-A (Series 1), -B (Series 1), -B (Series 3), -A,B (Series 1), -D (Series 4), -D (Series 5) Galileo /Neo Automated Blood Bank System License: U.S. License No Antibody Identification (P) Manufacturer: Micro Typing Systems, Inc. an Ortho Clinical-Diagnostics Company, Raritan NJ Test Name: MTS Anti-IgG Card Reagent Red Blood Cells 0.8% Resolve Panel A and Panel B ProVue Analyzer License: U.S. License No and 1236 Alternate Antibody Identification (P) Manufacturer: ImmucorGamma., Norcross, GA Test Name: Capture-R Ready ID, Extend I and Extend II License: U.S. License No Antibody Screen (P, D, T) Manufacturer: ImmucorGamma., Norcross, GA Test Name: Capture-R Ready Screen (Pooled) License: U.S. License No for Capture-R Ready Screen test wells only and BK Alternate Antibody Screen (P, D, T) Manufacturer: Micro Typing Systems, Inc. an Ortho Clinical-Diagnostics Company, Raritan NJ Test Name: MTS Anti-IgG Card Reagent Red Blood Cells 0.8% Surgiscreen ProVue Analyzer License: U.S. License No and 1236 Page 1 of 12
2 Blood Screening Assays Anti-HBc (ChLIA) (P, D, T) Test Name: Abbott PRISM HBcore, Hepatitis B Virus Core Antigen (E. coli, Recombinant) Anti-HCV (ChLIA) (P, D, T) Test Name: Abbott PRISM HCV, Hepatitis C Virus Encoded Antigens (Recombinant c100-3, HCr43, NS5) Generation: 2 Anti-HIV-1/HIV-2 ChLIA (P, D, T) Test Name: Abbott PRISM HIV O Plus, Human Immunodeficiency Virus Types 1 and 2 (E. coli, B. megaterium, Recombinant) Antigen and Synthetic Peptide Anti-HTLV-I/HTLV-II (ChLIA) (P, D, T) Test Name: Abbott PRISM HTLV-I/HTLV-II, Human T-Lymphotropic Virus Types I and II Babesia (P, T) Manufacturer: Immunetics, Inc. Test Name: Babesia microti ELISA Kit License: Information not available NOTE: This assay is for investigational use only and requires IRB approval prior to implementation. Cholesterol (P, D, T) Manufacturer: Beckman Coulter, Inc. Test Name: Cholesterol License: Information not available Cytomegalovirus (CMV) Screen (P, D, T) Manufacturer: Fujirebio Diagnostics, Inc. Malvern, PA Beckman Coulter Test Name: Beckman Coulter PK CMV-PA Test System and Controls PK7200 and PK7300 Automated Immunohematology Analyzers License: BK Ferritin (P, D, T) Manufacturer: Beckman Coulter, Inc. Test Name: Ferritin License: Information not available Page 2 of 12
3 Blood Screening Assays HBsAg (ChLIA) (P, D, T) Test Name: Abbott PRISM HBsAg, Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal IgM) Hemoglobin A1c (D) Manufacturer: Beckman Coulter, Inc. Test Name: HbA1c (Hemoglobin A1c) License: U.S. License No Nucleic Acid Testing (NAT) Procleix Parvo/HAV (licensed for use with cadaveric samples) Manufacturer: Hologic Inc., San Diego, CA Test Name: Procleix Parvo/HAV Assay License: Information not available (D) Nucleic Acid Testing (NAT) Procleix Ultrio Plus (P, D, T) (licensed for use with cadaveric samples) Manufacturer: Hologic Inc., San Diego, CA Test Name: Procleix Ultrio Plus Assay License: U.S. License No Nucleic Acid Testing (NAT) Procleix WNV RNA (P, D, T) Manufacturer: Hologic Inc., San Diego, CA Test Name: Procleix WNV Assay License: U.S. License No Rh + K Phenotyping (P, D, T) Manufacturer: Diagast, Cedex Loos, France for Beckman Coulter PK Systems Test Name: Blood Grouping Reagents (for the Beckman Coulter PK Systems) License: U.S. License No Syphilis Serology (P, D, T) Manufacturer: Fujirebio Diagnostics, Inc. Brea, CA for Beckman Coulter. Test Name: Beckman Coulter PK TP System PK7200 and PK7300 Automated Immunohematology Analyzers License: BK T. cruzi Antibody ChLIA (P, D, T) Test Name: Abbott PRISM Chagas, Trypanosoma cruzi (E. coli, Recombinant) Antigen Page 3 of 12
4 Parvovirus B19 / HAV Testing Parvovirus B19 Manufacturer: Test Name: License: (P) Roche Molecular Systems, Inc. cobas TaqScreen DPX Test Information not available Parvovirus B19 / HAV (P) Manufacturer: Test Name: License: Roche Molecular Systems, Inc. cobas TaqScreen DPX Test Information not available TRALI Mitigation Testing Donor Screen- HLA Class I and II (D, P, T) Manufacturer: GTI Diagnostics Crossroads Circle, Suite 200, Waukesha, WI Test Name: Donor Screen- HLA Class I and II License: BK Page 4 of 12
5 Source Plasma Anti-HCV (ChLIA) (P, D, T) Test Name: Abbott PRISM HCV, Hepatitis C Virus Encoded Antigens (Recombinant c100-3, HCr43, NS5) Generation: 2 Anti-HIV-1/HIV-2 ChLIA (P, D, T) Test Name: Abbott PRISM HIV O Plus, Human Immunodeficiency Virus Types 1 and 2 (E. coli, B. megaterium, Recombinant) Antigen and Synthetic Peptide HBsAg (ChLIA) (P, D, T) Test Name: Abbott PRISM HBsAg, Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal IgM) Nucleic Acid Testing (NAT) Procleix Parvo/HAV Assay Manufacturer: Hologic, Inc, San Diego, CA Test Name: Procleix Ultrio Plus Assay License: N/A (D) Nucleic Acid Testing (NAT) Procleix Ultrio Plus (P, D, T) (licensed for use with cadaveric samples) Manufacturer: Hologic, Inc, San Diego, CA Test Name: Procleix Ultrio Plus Assay License: U.S. License No Page 5 of 12
6 Source Plasma Ancillary Testing RPR (P, T) Manufacturer: Arlington Scientific, Inc., Springville, UT Test Name: ASI RPR Card Test for Syphilis License: Not Applicable Serum Protein Electropheresis (P) Manufacturer: Sebia Electrophoresis, Norcoss, GA Test Name: Capillarys Protein (E) 6 License: Not Applicable Total Protein (P) Manufacturer: Beckman Coulter, Inc. Test Name: Total Protein License: Not Applicable ABO/Rh (P, D, T) Manufacturer: Diagast, Loos Cedex, France for Beckman Coulter Test Name: Beckman Coulter PK System Blood Grouping and Phenotyping ReagentsPK7200 and PK7300 Automated Immunohematology Analyzers License: U.S. License No Antibody Screen (P, D, T) Manufacturer: ImmucorGamma., Norcross, GA Test Name: Capture-R Ready Screen (Pooled) License: U.S. License No for Capture-R Ready Screen test wells only and BK Page 6 of 12
7 Supplemental/Confirmatory Assays and Alternate Screening Assays Anti-HBc EIA (P) Manufacturer: ORTHO-Clinical Diagnostics, Inc., Raritan, NJ Test Name: ORTHO Hepatitis B Virus Core Antigen (Recombinant) ORTHO HBc ELISA Test System License: U.S. License No Anti-HBs EIA (P) Manufacturer: Bio-Rad Laboratories, Redmond, WA Test Name: Monolisa Anti-HBs EIA License: Not applicable Anti-HCV EIA (licensed for use with cadaveric samples) (P) Manufacturer: ORTHO-Clinical Diagnostics, Inc., Raritan, NJ Test Name: Hepatitis C Virus Encoded Antigen (Recombinant c22-3, C200 and NS5) ORTHO HCV Version 3.0 ELISA Test System License: U.S. License No Anti-HIV-1 IFA (P) Manufacturer: Sanochemia Pharmazeutika AG Vienna, Austria Test Name: Immunodeficiency Virus Type 1 (HIV-1): Fluorognost HIV-1 IFA License: U.S. License No Anti-HIV-2 EIA (P) Manufacturer: Bio-Rad Laboratories Blood Virus Division Redmond, WA Test Name: Human Immunodeficiency Virus Type 2, GS License: U.S. License No Anti-HIV-1/2 Plus O EIA (licensed for use with cadaveric samples) (P) Manufacturer: Bio-Rad Laboratories Blood Virus Division Redmond, WA Test Name: Human Immunodeficiency Virus Types 1 and 2 (Recombinant and Synthetic Peptides) GS HIV-1/HIV-2 Plus O EIA License: U.S. License No Anti-HTLV-I/II Confirmatory Assay (P) Manufacturer: MP Biomedicals Asia Pacific Pte. LTD Test Name: HTLV Blot 2.4 Western Blot Assay License: Not applicable US Patent 5,066,579; 5,614,366; 5,763,572 ; 5,814,441 ; 5,871,933 ; 5,643,714: Geenius HIV 1//2 Supplemental Assay (P) Manufacturer: Bio-Rad Laboratories, Inc. Test Name: Geenius HIV 1/2 Supplemental Assay License: Not applicable HBsAg Confirmatory ChLIA (P) Test Name: Abbott PRISM Antibody to Hepatitis B Surface Antigen (Human) HBsAg EIA (licensed for use with cadaveric samples) (P) Manufacturer: Bio-Rad Laboratories Blood Virus Division, Redmond, WA Test Name: Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal):GS HBsAg EIA 3.0 License: U.S. License No. 1109, Generation 3 Page 7 of 12
8 Supplemental/Confirmatory Assays and Alternate Screening Assays HBsAg EIA Neutralization (P) Manufacturer: Bio-Rad Laboratories Blood Virus Division Redmond, WA Test Name: Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal) GS HBsAg Confirmatory Assay 3.0 License: U.S. License No HTLV I/II EIA (Avioq) (P) Manufacturer: Avioq, Inc., Research Triangle Park, North Carolina Test Name: Avioq HTLV-I/II Microelisa System License: U.S. License No Nucleic Acid Testing (NAT) Procleix Ultrio Plus Discriminatory dhbv (P, T) (licensed for use with cadaveric samples) Manufacturer: Hologic, Inc., San Diego, CA Test Name: Procleix Ultrio Plus dhbv Assay License: U.S. License No Nucleic Acid Testing (NAT) Procleix Ultrio Plus Discriminatory dhcv (P, T) (licensed for use with cadaveric samples) Manufacturer: Hologic, Inc., San Diego, CA Test Name: Procleix Ultrio Plus dhcv Assay License: U.S. License No Nucleic Acid Testing (NAT) Procleix Ultrio Plus Discriminatory dhiv-1 (P, T) (licensed for use with cadaveric samples) Manufacturer: Hologic, Inc., San Diego, CA Test Name: Procleix Ultrio Plus dhiv-1assay License: U.S. License No RPR and Quantitative RPR (P, T) Manufacturer: Arlington Scientific, Inc., Springville, UT Test Name: ASI RPR Card Test for Syphilis License: Not Applicable Syphilis-G EIA (P) Manufacturer: Trinity Biotech, Jamestown, NY Test Name: CAPTIA Syph - G License: Not Applicable T. cruzi Antigen ESA (P) Test Name: Abbott ESA Chagas, Trypanosoma cruzi (E. coli, Recombinant) Antigen Page 8 of 12
9 Supplemental/Confirmatory Assays and Alternate Screening Assays Referral Testing Services Assay available through Memorial Blood Centers Anti-T Cruzi EIA Assay available through Bloodworks Northwest Nucleic Acid Testing (NAT) cobas Unlicensed assays available through Quest Laboratories Anti-HBc IgM EBV IgG Toxoplasma IgG (Toxoplasma Gondii) WNV IgG Antibody WNV IgM Antibody Page 9 of 12
10 Component Quality Control WBC Counts on Leucoreduced Products LeucoCOUNT Kit (P) Manufacturer: Becton Dickinson Immunocytometry Systems, San Jose, CA Test Name: LeucoCOUNT Kit License: Information is not available Factor VIII and Fibrinogen on Cryoprecipitated and Fresh Frozen Plasma Units Dade-Behring Factor VIII Chromogenic Assay Manufacturer: Dade-Behring, Inc., Newark, DE Test Name: Factor VIII Chromogenic Assay License: Information is not available (P) Dade-Behring Multi-Fibren U Fibrinogen Assay (P) Manufacturer: Dade-Behring, Inc., Newark, DE Test Name: Fibrinogen Assay License: Information is not available Dade-Behring Standard Human Plasma (P) Manufacturer: Dade-Behring, Inc., Newark, DE Test Name: Factor VIII Chromogenic Assay License: Information is not available Bacterial Detection for Leukoreduced Platelet Components BacT/ALERT SA (P) Manufacturer: biomérieux, Inc. Test Name: BacT/ALERT License: Information is not available Page 10 of 12
11 Revision History The following table represents the revision history of this document. Date Revised Reason for Change 11/17/17 Added Procleix Parvo/HA 10/08/17 Removed Roche NAT and WNV Updated manufacturer and license number for NAT Procleix Ultrio 01/25/17 Plus and Procleix WNV 12/19/16 Discontinuation of HIV-2 Western Blot Implementation of Geenius HIV-1/2 Supplemental Assay 07/01/16 Addition cobas Taqscreen MPX 2.0 Discontinuation of AmpliScreen and FTA 05/17/16 Addition of MP HLTV Western Blot 2.4 Removal of HTLV Inno-LIA 11/23/15 Ferritin implementation Tampa Removed Alternate CMV on Galileo platform Added Babesia Added Tampa site to Ferritin Added Source Plasma section: Anti HIV 1/HIV 2 Anti-HCV 09/21/15 HbsAg Procleix Ultrio plus assay ABO/Rh Antibody Screen RPR Serum Protein Electropheresis Total Protein Addition of Roche NAT HCV in Phoenix 08/20/15 Addition of HbA1c in Dallas Addition of Generation HCV ChLIA and HbsAg EIA 07/10/15 Removed Referral testing from Illinois Department of Health 04/01/15 Removed CTS Chicago and added Ferritin 03/23/15 Implementation of Rh, kell in Tampa Addition of T. Cruzi ESA 11/04/14 Addition of Syphilis FTA Addition of Phoenix location to HLA Screen Class I and II 09/23/14 Removed T. cruzi Antibody RIPA 04/14/14 Removed Dallas and Tampa locations from Antibody ID assay Addition of Reference testing of Anti-T Cruzi 02/03/14 Removal of Reference testing of Anti- HCV 09/17/13 NEO implementation for Red Cell Testing 07/15/13 Prism implementation for viral marker testing 07/01/13 Prism implementation for T. Cruzi testing 04/15/13 Implementation of Procleix Ultrio plus assay Updated Supplemental/Confirmatory section to reflect 03/11/13 consolidation of Tampa and Phoenix Special Testing Added assays performed by CTS Chicago 01/01/13 Updated Parvo B19 assay to Roche Page 11 of 12
12 Removed LabScreen Mixed Class I and II Antibodies 11/06/12 Removed HCV RIBA from Supplemental Assays Added Anti-HCV ChLIA to Referral Testing 05/21/12 Updated the HTLV assays from Prism to Avioq. Removed ALT assay from Supplemental/Confirmatory under 04/26/12 Referral Assays. 04/17/12 Update Vendor Name from Olympus to Beckman Coulter 03/19/12 Updated the Anti-HBc and HBsAg assays from Prism to Ortho 01/17/12 Added the Donor Screen HLA Class I and Class II Removed Bio-Rad Anti-HIV-1 EIA from Supplemental/ 3/28/11 Confirmatory Assays list. Moved Roche PCR assays from Supplemental/Confirmatory to 10/28/10 Referral Assays. Removed NAT Procleix HIV-1/HCV assay from Blood Screening 10/13/10 Assays. Added NAT HIV-1/HCV/HBV Ultrio to Blood Screening Assays. 8/2/10 Added NAT Discriminatory dhbv to Supplemental/Confirmatory Assays. Removed Abbott Anti-HTLV-I/II EIA from Supplemental/ 4/19/10 Confirmatory Assays. Page 12 of 12
Confirmatory Testing Algorithm. Routine Donor Testing Algorithm
Confirmatory Testing Algorithm Blood Confirmatory ABO/Rh Beckman Coulter PK-ABO/Rh Immucor NEO ABO/Rh Immucor NEO ABO/Rh Immucor Manual ABO/Rh Typing Immucor Manual ABO/Rh Typing Discrepancy Resolution
Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma
Test Name *Minimum Collection Tubes Sample Stability ABO/Rh Blood Typing 50 µl cells EDTA whole blood (lavender-top) Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma
The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing
PERMISSON TO USE: Please note that, by making their presentations available on-line, primary authors have agreed to share their presentations. However, should you want to use some of the data or slides
Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia
Donor Screening in The Region Vincini GA NRL, Melbourne, Australia NRL Established in 1985 Not-for-profit organisation that exists to support laboratories that perform testing for the diagnosis and management
The testing of Donated Blood and Components at NHSBT
The testing of Donated Blood and Components at NHSBT NHSBT is responsible for collecting all donated blood and platelets in England, then processing into components before issuing to client hospitals.
FDA Reentry Guidance
FDA Reentry Guidance T. cruzi - Chagas, Hepatitis C and HIV Wednesday 6/6/18 Doug Denyer O Dina Hurlburt, SBB(ASCP)CM Outline Impact to Clients Review of FDA Guidance Documents Reentry Request Process
NAT Screening of Blood Donations in NBC, TRCS
IPFA/PEI, Italy NAT Screening of Blood Donations in NBC, TRCS 2000-2001 Clinical evaluation using COBAS AmpliiScreen HIV & HCV assays, (MP24) window period rate - 1 : 108,768 for HIV-1 and HCV 2002 Routine
Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention
Evolution of HIV Diagnostics and Goals for the 2010 Conference Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics CDC Division of HIV/AIDS Prevention Evolution or other influences like
Schedule of Accreditation
Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319
EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK
National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on
SOLE-SOURCE DETERMINATION
SOLE-SOURCE DETERMINATION The Purchasing Division has been requested to approve a sole source purchase for the commodity or service described below. Pursuant to West Virginia Code 5A-3-10c, the Purchasing
Non-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC and its technical Directives (particularly 2006/17/EC) More stringent -legally binding, applies for all donations and all donor profiles
National Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands. TransMed conference Bhopal 18 November 2016
Dr. Anton van Weert National Screening laboratory Sanquin The use of NAT in blood donation screening in The Netherlands TransMed conference Bhopal 18 Introduction Thank you! Anton van Weert, PhD, MBA Manager
Non-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More stringent - recommended Not legy binding and not recommended Tested pathogen Donor test/ technique
Non-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding
AccuSet HIV-1/2 Performance Panel
OVERVIEW AccuSet HIV-1/2 (0800-0380) is a 13-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent bleeds from multiple
Non-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding on national level More stringent - recommended on national level Not legy binding and not recommended on
Keeping the Blood Supply Safe Current and Future Strategies. Marissa Li, MD
Keeping the Blood Supply Safe Current and Future Strategies Marissa Li, MD Overview Pre-collection Donor Screening Collection Visual Inspection Aseptic Processing Leukoreduction of Apheresis Collections
Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen
Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of
Maximizing Cornea and Tissue Donation through Specimen Quality
Maximizing Cornea and Tissue Donation through Specimen Quality Robert W. Bresler, Sydney D. Gastreich, Elias G. Koulouriotis, Linda S. Martin, Susan Diane Brockmeier, Chak-Sum Ho, PhD Abstract Purpose:
Quotient Limited. 36 th Annual JP Morgan Healthcare Conference. San Francisco, January 2018 THE FUTURE, MADE POSSIBLE
Quotient Limited 36 th Annual JP Morgan Healthcare Conference San Francisco, January 2018 Safe Harbor Statement This presentation contains forward-looking statements within the meaning of Section 27A of
FINAL REPORT HBV Serology External Quality Assessment Scheme
FINAL REPORT HBV Serology External Quality Assessment Scheme Programme codes: HBVC4310, HBVC435 Panel ID: 2008/Mar/11 HBV Serology EQAS Panel ID 2008/Mar/11 Page 1 of 9 The NRL is a: NATA-accredited proficiency
Non-reproductive tissues and cells
Colour key Tested pathogen VIRAL Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recommended on national level Not
Biokit Label Catalog. Living Immunoassay Excellence
Living Immunoassay Excellence Biokit Label Catalog Biokit is a privately owned biotechnological company that is part of Werfen. It was founded in 1973 and is aimed at the research, development, manufacture
2018 HIV and HCV Diagnostic Testing Survey
2018 HIV and HCV Diagnostic Testing Survey This survey is designed to capture the 2017 HIV and HCV testing practices in state and local public health laboratories (PHL). The results of the survey will
1 st and 2 nd Generation EIA
HIV Diagnostic Tests Bernard M. Branson, M.D. Associate D irector for Laboratory D iagnostics Division of HIV/AIDS Prevention Centers for D isease Control & Prevention The views expressed in this presentation
Transfusion Medicine (Comprehensive, Limited) J, J1
www.cap.org Transfusion Medicine Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Transfusion Medicine (Comprehensive, Limited)
MP Biomedicals Asia Pacific Pte. Ltd. (formerly Genelabs Diagnostics Pte. Ltd.)
Revision: 12 May 2005 1 WESTERN BLOT / IMMUNOBLOT HIV-1 BLOT Version 1.3* 11010-018 HIV-1 viral lysate Western Blot assay for the 11010-036 detection of antibodies to HIV-1 with serum 11010-108 108 strips
Screening Volunteer Blood Donations for Transmissible Infectious Diseases
Screening Volunteer Blood Donations for Transmissible Infectious Diseases Joan D. McAuley, MT(ASCP), CHS(ABHI), Gene F. Robertson, PhD (Blood Systems Laboratories, Tempe, AZ) DOI: 10.1309/YKW4JAF2RGFE3V0K
AccuVert HIV-1 Seroconversion Panel PRB955 ( ) / Batch #
Signal to cutoff (s/co) Copies per ml (c/ml) OVERVIEW AccuVert is a 5-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent
FINAL REPORT HBV Serology External Quality Assessment Scheme
FINAL REPORT HBV Serology External Quality Assessment Scheme Programme codes: HBVC4310, HBVC435 Panel ID: 2008/Oct/28 HBV Serology EQAS Panel ID 2008/Oct/28 Page 1 of 11 The NRL is a: NATA-accredited proficiency
TRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:
I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION: A. TRANSFUSION RELATED FATALITY: FDA and MEDIC must be notified immediately, and subsequently in writing, when a possible transfusion related
: New graphic materials for bioelisa and bioblot product lines
1 NEWS BK NEWS # 385 /BE/ MKT DATE : 24-05-2016 TITLE : New graphic materials for bioelisa and bioblot product lines Dear colleagues, We are pleased to present the new materials for bioelisa and bioblot
Guidance for Industry
Guidance for Industry Advisement for the Use of Gen-Probe Procleix Ultrio Plus Assay for NAT Testing on Cadaveric Donors Release Date: 08/03/14 American Medical Education and Research Association 4757
Probability of false initial and repeat ID-NAT reactive donations. Marion Vermeulen IPFA Rome 2014
Probability of false initial and repeat ID-NAT reactive donations Marion Vermeulen IPFA Rome 2014 Overview of SANBS SANBS is a non profit organization Provides a vein to vein blood transfusion service
Update from ISS on following EQA studies: ISS EQA Tri-NAT (HCV, HIV and HBV) 2012 ISS EQA NAT HBV 2012 ISS EQA NAT WNV 2012
Update from ISS on following EQA studies: ISS EQA Tri-NAT (HCV, HIV and HBV) 2012 ISS EQA NAT HBV 2012 ISS EQA NAT WNV 2012 SOGAT XXIV Ljubljana, 8-9 May 2013 2012 ISS EQAs for NAT ISS EQA Tri-NAT (HCV,
Routine Use of Mini-Pool Nucleic Acid Testing (MP-NAT) Multiplex Assay for Sero-Negative Blood Donors
Journal of the Egyptian Society of Haematology & Research, Vol. 7, No. 2, September: 1-5, 2011 Routine Use of Mini-Pool Nucleic Acid Testing (MP-NAT) Multiplex Assay for Sero-Negative Blood Donors HISHAM
HEV Assay Development Update
HEV Assay Development Update Jeffrey M. Linnen, Ph.D. Senior Director, Research & Development Hologic Gen-Probe, San Diego, California USA IPFA/PEI 20th International Workshop on Surveillance and Screening
Quality Control Solutions
Quality Control Solutions 1 CONTENT QCONNECT 3 ABOUT DIAMEX 6 ABOUT NRL 7 ABOUT EXACT DIAGNOSTICS 7 PRODUCTS 8 SEROLOGY MULTIMARKER RANGE 10 SEROLOGY SINGLE ANALYTE RANGE 16 NAT CONTROL RANGE 19 EXACT
Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.
Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India. Cinzia Keechilot, Veena Shenoy 1,V Anil kumar 2,Lalita Biswas 3. MBBS student * Transfusion
Laboratory Diagnosis of Viral Infections. G. Jamjoom 2005
Laboratory Diagnosis of Viral Infections G. Jamjoom 2005 Five Main Techniques: Virus Culture and Isolation Serology Rapid Detection of Viral Antigens Detection of Viral Nucleic Acid Electron Microscopy
Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
Infectious Disease Controls for Serology Testing
Infectious Disease Controls Infectious Disease Controls for Serology Testing A comprehensive guide for monitoring testing for Hepatitis, Retrovirus, Sexually Transmitted and Congenital Diseases Table of
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK West of Scotland Specialist Virology Centre New Lister Building Level 5 Glasgow Royal Infirmary 10-16 Alexandra Parade Glasgow G31 2ER Contact:
Table of Contents (continued)
Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping
HIV-1 AccuVert TM Seroconversion Panel
PACKAGE INSERT PRB954 (0600-0238) INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot test methods. Characterized
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and
AccuVert HBV Seroconversion Panel PHM941(M) ( )
PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics
Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016
New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new
Non-reproductive tissues and cells
Ministry of Health: Institute for Transplantation and Biomedicine / Colour key VIRAL HIV 1 and HIV 2 Hepatitis B Minimum requirements as set out in Directive 2004/23/EC More stringent - legy binding More
Living Immunoassay Excellence
Living Immunoassay Excellence Catalog 2016 Biokit is a privately owned biotechnological company that is part of Werfen. It was founded in 1973 and is aimed at the research, development, manufacture and
Impact of multi-dye multiplex technology on testing algorithm
Impact of multi-dye multiplex technology on testing algorithm Lydia Blanco. Mª Isabel Gonzalez-Fraile Centro de Hemoterapia y Hemodonación de Castilla y León, España TTI EPIDEMIOLOGICAL DATA IN SPAIN NAT
The Alphabet Soup of Viral Hepatitis Testing
The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,
risk of Transfusion-Transmitted Transmitted Viral Infections (HIV, HCV and HBV)
Prevention and ResidualR risk of Transfusion-Transmitted Transmitted Viral Infections (HIV, HCV and HBV) Syria Laperche L (Centre National de référence r rence pour les hépatites h B et C en Transfusion)
Non-reproductive tissues and cells
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legally binding on national level More stringent testing - recommended on national level Not legally binding
Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories
Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories Blood Products From the Donor to You Objectives Deliver a brief virtual tour of a blood center. Describe the number of donors needed to meet the
List of HIV diagnostics eligible to tender for procurement by WHO in 2011
Since 1988, WHO has performed assessments of commercially available diagnostics for HIV, hepatitis B, hepatitis C and Chagas disease. Up to 2006, this process was called the WHO Test Kit Evaluation programme,
HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS. Joana Bikulčienė Director of National blood center
HEPATITIS SCREENING IN THE LITHUANIAN BLOOD ESTABLISHMENTS Joana Bikulčienė Director of National blood center j.bikulciene@kraujodonoryste.lt Organizational structure of Lithuanian blood service 1 specialized
Non-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent - legally binding More stringent - recommended Not legally binding and not recommended Non-reproductive tissues and cells
AccuVert HIV-1 Seroconversion Panel PRB974 ( )
PACKAGE INSERT PRB974 (0600-0258) INTENDED USE PRB974 (0600-0258) is a group of serial bleeds from an individual plasma donor during seroconversion. This panel is intended for use by diagnostics manufacturers
Sensitivity of the Procleix HIV-1/HCV Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA in a High-Risk Population
JOURNAL OF CLINICAL MICROBIOLOGY, July 2002, p. 2387 2391 Vol. 40, No. 7 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.7.2387 2391.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
TEST REQUEST INFORMATION- VIROLOGY
Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport
New HIV Tests and Algorithm: A change we can believe in
New HIV Tests and Algorithm: A change we can believe in Esther Babady, PhD, D (ABMM) Memorial Sloan-Kettering Cancer Center New York, New York Learning Objectives After this presentation you should be
Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed
Seroconversion OVERVIEW HIV-1 AccuVert TM Seroconversion PRB970 is a 4 member, 1.0 ml per vial panel of undiluted, naturally-occurring plasma samples. members represent serial bleeds collected from a single
Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance
Infectious Disease Testing ULTRA Product Line Safety is not a Matter of Chance ULTRA Product Line The best answer for HBV, HCV and HIV screening: a global automated solution for safe results. Monolisa
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Royal Liverpool & Broadgreen University Hospitals NHS Trust Department of Virology Liverpool Clinical Laboratories Royal Liverpool and Broadgreen
Human Immunodeficiency Virus Serology
Participant No: _ Human Immunodeficiency Virus Serology Survey No: RT :20 Please print the document labelled Clinical Notes & Test Instructions and enter your results via myqap. Kit Information Please
Non-reproductive tissues and cells Recommending authority/ association
Colour key Minimum requirements as set out in Directive 2004/23/EC More stringent testing - legy binding on national level More stringent testing - recomd on national level Not legy binding and not recomd
HTLV Serology Quality Assessment Program Summary for Panel HTLS Oct22
National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLS425 2015Oct22
Trends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa
Answering your daily challenges in the ELISA technology I N FECTI OUS DISEASES bioelisa RETROVIRUS HIV is the cause of the most important global pandemic. Due to the lack of vaccination, early diagnosis
CARIBBEAN REGION EXTERNAL QUALITY ASSESSMENT SCHEME. Evaluation Booklet. Performance Evaluation Panel OPS0106 C. Coordination:
EXTERNAL QUALITY ASSESSMENT SCHEME Evaluation Booklet CARIBBEAN REGION Performance Evaluation Panel OPS0106 C Coordination: Fundação Pró-Sangue Hemocentro de São Paulo Pan American Health Organization
A. Anti-HIV-1/2, HIV NAT Lookback: for those identified blood and blood components collected:
PURPOSE: MATERIALS: To outline a procedure for removing, recalling and/or correcting blood products that do not meet the requirements of the FDA, AABB, or the blood center. Recall/Market Withdrawal Form
NEWS BK NEWS # 378 /MKT DATE : TITLE. Dear colleagues,
1 NEWS BK NEWS # 378 /MKT DATE : 16022016 TITLE : New Bioelisa reagents Brochures Dear colleagues, We are pleased to present the new Bioelisa reagents Brochures, which are a very useful marketing and selling
HIV-1 Seroconversion Panel
OVERVIEW This Data Sheet contains test results specific for HIV-1. s are undiluted aliquots from plasma units collected from a single donor. No preservatives were added. CAUTION: Potentially infectious
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Luton and Dunstable University Hospital NHS Foundation Trust Lewsey Road Luton Bedfordshire LU4 0DZ Contact: Pauline Philip Tel: +44 (0)1582
HIV Testing Technology and the Latest Algorithm
HIV Testing Technology and the Latest Algorithm David Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene HIV Testing has changed over time Patients with
DAT-B 2015 Direct Antiglobulin Test
EVALUATION DAT-B 2015 Direct Antiglobulin Test INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 28002258 10/12/2015 11/16/2015 Next Mailing Date: 2/22/2016 COPIED TO: LAP
Treponema-Specific Tests for Serodiagnosis of Syphilis: Comparative Evaluation of Seven Assays
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1313 1317 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.02555-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Treponema-Specific
Viral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
Understanding Transfusion Medicine
Understanding Transfusion Medicine Every minute of every day, blood is on a critical journey A Reference Guide for Journalists Overview of Transfusion Medicine Every second, three people across the world
WHO list of prequalified in vitro diagnostic products
WHO list of in vitro diagnostic products : Rest of the world. Regulatory version applied to products not approved by stringent/mature NRAs or not regulated Last update: 8 April 2016 Year 2016 HIV RDT OraQuick
100 Abbott Park Road Abbott Park, IL Trade Name: ARCHITECT HIV Ag/Ab Combo Assay Approved Date: 18-JUN-2010
Currently Approved CBER Device Premarket Applications (PMAs) As of Nov 10, 2014 Sorted by Applicant Name BP090080-0 BP060002-0 BP120037-0 BP090022-0 BP090032-0 BP040046-0 BP100064-0 BP140120-0 Abbott Laboratories
With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV 1+2 Ag/Ab from 10 to 12 months.
1 NEWS BK NEWS # 377 /MKT DATE : 18-01-2016 TITLE : SHELF-LIFE EXTENSION OF bioelisa HIV 1+2 Ag/Ab With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV
Controls & Calibrators. Disease Quality Controls
Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted
AccuSet HCV Performance Panel
Signal to cutoff (s/co) DATA SHEET OVERVIEW AccuSet HCV (0810-0204) is a 25-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members
HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19
National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary
Evaluation of run controls for cobas 6800 MPX and HEV assay
Evaluation of run controls for cobas 6800 MPX and HEV assay Marco Koppelman Head of Nucleic Acid testing (NAT) laboratory, National Screening laboratory of Sanquin (NSS) in the Netherlands Satellite Meeting
Multichem Infectious Disease QC
Infectious Disease QC Contents Introduction....3 Quality Control in the Laboratory...4 Infectious Disease (ID) QC....5 Ready-to-use Concept....6 NRL...7 QConnect...8 IAMQC in Collaboration with QConnect....
Structure and duties of Blood service
NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,
HIV-1 Seroconversion Panel PRB973
A SERACARE PANEL PRODUCT INTENDED USE The is a group of serial bleeds from an individual plasma donor during seroconversion. This panel is intended for use by diagnostics manufacturers and clinical laboratorians
The Food and Drug Administration (FDA) has
NAT Comparative analysis of triplex nucleic acid test assays in United States blood donors Susan L. Stramer, David E. Krysztof, Jaye P. Brodsky, Tracy A. Fickett, Benjamin Reynolds, Roger Y. Dodd, and
Customer Service and Ordering Biologicals Quality Control B.V. Droogmakerij 31h 1851 LX Heiloo The Netherlands
PRODUCT CATALOGUE Customer Service and Ordering Biologicals Quality Control B.V. Droogmakerij 31h 1851 LX Heiloo The Netherlands Communication +31 72 202 07 30 +31 72 202 07 31 info@bioqcontrol.com www.bioqcontrol.com
Impact of Testing Strategies to Reduce Transmission Risk for HBV. Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013
Impact of Testing Strategies to Reduce Transmission Risk for HBV Ravi Reddy, M Vermeulen South African National Blood Service (SANBS) 29 July 2013 Overview of SANBS SANBS is a private not for profit company
HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19
National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary
QUALITY CONTROL Infectious Disease
QUALITY CONTROL Infectious Disease 1 Infectious Disease Quality Control The human based material used in the production of our Quality Controls is sourced from the Taiwan Blood Services Foundation (TBSF).
2006 HIV Diagnostics Survey
Public Health Laboratory Issues in Brief: 2006 HIV Diagnostics Survey Association of Public Health Laboratories November 2007 Background Nearly 20 years ago, the Association of Public Health Laboratories
Documentation, Codebook, and Frequencies
2 Documentation, Codebook, and Frequencies Laboratory Component: Hepatitis B: core antibody, surface antibody and surface antigen; Hepatitis C: confirmed antibody; Hepatitis D antibody Survey Years: 2003
Surveillance Report 2014
Surveillance Report 2014 Executive summary We are pleased to present the third report for our stakeholders describing infectious disease surveillance. High quality and timely surveillance is key to the